Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">PW02-011 - Favorable response to anakinra in aisle patients</title><author><name sortKey="Ozdogan, H" sort="Ozdogan, H" uniqKey="Ozdogan H" first="H" last="Ozdogan">H. Ozdogan</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Gattorno, M" sort="Gattorno, M" uniqKey="Gattorno M" first="M" last="Gattorno">M. Gattorno</name><affiliation><nlm:aff id="I2">EULAR Centre of Excellence in Rheumatology 2008-13, "G. Gaslini" Scientific Institute, Genova, Italy</nlm:aff></affiliation></author><author><name sortKey="Ugurlu, S" sort="Ugurlu, S" uniqKey="Ugurlu S" first="S" last="Ugurlu">S. Ugurlu</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Di Rocco, M" sort="Di Rocco, M" uniqKey="Di Rocco M" first="M" last="Di Rocco">M. Di Rocco</name><affiliation><nlm:aff id="I2">EULAR Centre of Excellence in Rheumatology 2008-13, "G. Gaslini" Scientific Institute, Genova, Italy</nlm:aff></affiliation></author><author><name sortKey="Hatemi, G" sort="Hatemi, G" uniqKey="Hatemi G" first="G" last="Hatemi">G. Hatemi</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Ustek, D" sort="Ustek, D" uniqKey="Ustek D" first="D" last="Ustek">D. Ustek</name><affiliation><nlm:aff id="I3">Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Gul, A" sort="Gul, A" uniqKey="Gul A" first="A" last="Gul">A. Gul</name><affiliation><nlm:aff id="I4">Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmc">3953153</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953153</idno><idno type="RBID">PMC:3953153</idno><idno type="doi">10.1186/1546-0096-11-S1-A151</idno><idno type="pmid">NONE</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">001D50</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001D50</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">PW02-011 - Favorable response to anakinra in aisle patients</title><author><name sortKey="Ozdogan, H" sort="Ozdogan, H" uniqKey="Ozdogan H" first="H" last="Ozdogan">H. Ozdogan</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Gattorno, M" sort="Gattorno, M" uniqKey="Gattorno M" first="M" last="Gattorno">M. Gattorno</name><affiliation><nlm:aff id="I2">EULAR Centre of Excellence in Rheumatology 2008-13, "G. Gaslini" Scientific Institute, Genova, Italy</nlm:aff></affiliation></author><author><name sortKey="Ugurlu, S" sort="Ugurlu, S" uniqKey="Ugurlu S" first="S" last="Ugurlu">S. Ugurlu</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Di Rocco, M" sort="Di Rocco, M" uniqKey="Di Rocco M" first="M" last="Di Rocco">M. Di Rocco</name><affiliation><nlm:aff id="I2">EULAR Centre of Excellence in Rheumatology 2008-13, "G. Gaslini" Scientific Institute, Genova, Italy</nlm:aff></affiliation></author><author><name sortKey="Hatemi, G" sort="Hatemi, G" uniqKey="Hatemi G" first="G" last="Hatemi">G. Hatemi</name><affiliation><nlm:aff id="I1">Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Ustek, D" sort="Ustek, D" uniqKey="Ustek D" first="D" last="Ustek">D. Ustek</name><affiliation><nlm:aff id="I3">Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author><author><name sortKey="Gul, A" sort="Gul, A" uniqKey="Gul A" first="A" last="Gul">A. Gul</name><affiliation><nlm:aff id="I4">Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey</nlm:aff></affiliation></author></analytic><series><title level="j">Pediatric Rheumatology Online Journal</title><idno type="eISSN">1546-0096</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pmc article-type="abstract" xml:lang="en"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Rheumatol Online J</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Rheumatol Online J</journal-id><journal-title-group><journal-title>Pediatric Rheumatology Online Journal</journal-title></journal-title-group><issn pub-type="epub">1546-0096</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3953153</article-id><article-id pub-id-type="publisher-id">1546-0096-11-S1-A151</article-id><article-id pub-id-type="doi">10.1186/1546-0096-11-S1-A151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Meeting Abstract</subject></subj-group></article-categories><title-group><article-title>PW02-011 - Favorable response to anakinra in aisle patients</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Ozdogan</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Gattorno</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Ugurlu</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Di Rocco</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Hatemi</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Ustek</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" corresp="yes" id="A7"><name><surname>Gul</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib></contrib-group><aff id="I1"><label>1</label>Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey</aff><aff id="I2"><label>2</label>EULAR Centre of Excellence in Rheumatology 2008-13, "G. Gaslini" Scientific Institute, Genova, Italy</aff><aff id="I3"><label>3</label>Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey</aff><aff id="I4"><label>4</label>Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>8</day><month>11</month><year>2013</year></pub-date><volume>11</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)</named-content></supplement><fpage>A151</fpage><lpage>A151</lpage><permissions><copyright-statement>Copyright © 2013 Ozdogan et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Ozdogan et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.ped-rheum.com/content/11/S1/A151"></self-uri><conference><conf-date>22-26 May 2013</conf-date><conf-name>7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)</conf-name><conf-loc>Lausanne, Switzerland</conf-loc></conference></article-meta></front><body><sec><title>Introduction</title><p>We previously described a new autosomal recessively inherited autoinflammatory syndrome in two Turkish patients, who were second-degree cousins. Their clinical features included recurrent inflammatory attacks lasting 3-10 days since the first year of life, which are characterized by fever, erythematous or urticarial rash with hyperesthesia, serositis and edema on the face and extremities. Both patients eventually developed a lymphedema symmetrically affecting lower extremities and genitalia. Using a homozygosity mapping approach and targeted capture array based sequencing, we identified a homozygous insertion mutation in the exon 3 of the MyoD family inhibitor domain containing gene (MDFIC), causing a frameshift and inhibiting the translation of its functional cysteine-rich C-terminal domain. We herein report another patient of Italian origin and also their response to anakinra treatment.</p></sec><sec><title>Case report</title><p>Italian patient, a 11 year-old girl healthy unrelated parents, had a history of caesarean section at 33th week of pregnancy, because of fetal subcutaneous tissue edema and pleural effusion. Within the first 24 h, she developed respiratory distress, and pleural effusion was drained the intensive care unit. She required ventilatory support, antibiotics and diuretics for 2 months. At the age of 9 months hearing loss due to mutation 35delG of GJB2 gene was detected and cochlear implantation was subsequently done. At the age of 2 yr, she started to have attacks of fever, limb edema, severe pleural and pericardial effusions requiring urgent pleural and pericardial fluid drainage. Laboratory investigations showed a severe anemia and elevated acute phase response, and she only responded to high dose methylprednisolone. At the age of 8 yr, she had recurrent attacks during tapering of steroids. Anakinra was started at the dosage of 2 mg/kg/day with a dramatic control of inflammatory manifestations and acute phase response. After 6 months of continuous treatment anakinra was tapered to every other day injections. Sequencing of the MDFIC gene of this patient revealed the same insertion mutation causing a frameshift.</p><p>Similarly, two Turkish cousins first tried canakinumab 150 mg every 4 weeks, but they continued to experience attacks on this treatment up to 3 to 4 months. Their treatment switched to anakinra during the last 4 months, and a favorable response (complete in the elder, and partial in the younger) was observed in both clinical and laboratory findings.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Identification of the same MDFIC gene mutation in an Italian patient with similar manifestations confirms the association of this variation with AISLE. Differential response to anakinra in those patients may suggest the importance of IL-1 alpha in its pathogenesis.</p></sec><sec><title>Disclosure of interest</title><p>None declared</p></sec></body></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D501 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001D501 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.31. |  |